MAIA MAIA Biotechnology, Inc. PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

MAIA Biotechnology (MAIA) Stock: Buy, Sell, or Hold?

$1.11
-0.03 (-2.63%) â–ŧ
5d: +11.0% 30d: -1.77% 90d: -17.78%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (70%)
Quality Score
37/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$1.05 – $1.18
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-2.3x CHEAP
vs 1.0x historical avg
Wall Street Target
$12.00
+981.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.96 / $1.44
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: MAIA is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.

Get Alerted When MAIA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: MAIA is currently trading at $1.11, which is considered slightly high relative to its 30-day fair value range of $1.05 to $1.18. From a valuation perspective, the stock is trading at a discount (Forward PE: -2.3) compared to its historical average (1.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $0.96, while resistance sits at $1.44.

Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.00 (+981.1%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $1.05 - $1.18
Company Quality Score 37/100 (SELL)
Volume Confirmation HIGH
Confidence Score 70.0%

Trading Range & Key Levels

30-Day Trading Range $1.05 - $1.18
Current vs Trading Range SLIGHTLY HIGH
Support Level $0.96
Resistance Level $1.44
Current Trend Strong Downtrend
Technical data as of Nov 20, 2026

Institutional Signals, 13F Whale Activity & Setup Structure

Quantitative Research Feed
30D Insider Cluster Signal CLUSTER BUY
30D Insider Buyers: 2 insiders ($149,526)
30D Net Insider Flow: +$149,526

Quantitative Signal Breakdown

  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 981.1% below Wall St target ($12.00)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -2.31
Wall Street Target $12.00 (+981.1%)
PE vs Historical -2.3 vs 1.0 CHEAP
Share MAIA Analysis

Share this live MAIA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (MAIA)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
Retail Stream Volume
1 msgs
24h retail stream
Last Tracked
Nov 22, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish StockTwits message suggests that big pharma companies may be interested in acquiring $MAIA due to the potential for expanding the market for its 3-letter treatment into a 1-letter market, leading to significant acquisition value.
Key Retail Themes: M&A speculation Market expansion potential
Aggregated from r/wallstreetbets, r/stocks & retail trader streams. View All Trending Reddit & WSB Stocks →
Last updated: November 22, 2026 5:06 AM ET
Data refreshes hourly during market hours. Next update: 6:06 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
IONS
Ionis Pharmaceuticals Inc
STRONG BUY
25 analysts
$69 65 BUY
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 50 HOLD
JANX
Janux Therapeutics Inc
STRONG BUY
18 analysts
$33 53 HOLD
BEAM
Beam Therapeutics Inc
STRONG BUY
15 analysts
$50 60 HOLD
TSHA
Taysha Gene Therapies Inc
STRONG BUY
13 analysts
$13 52 HOLD
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals